Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
E

ELV

NYSE

Elevance Health, Inc.

Latest disclosureOctober 6, 2026
Insider score Why 42?
42/ 100
Qualifying buys · 30d
$0

3 purchases · 3 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 25

Limited filing history
All25Buying3Selling3Other19
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

19 of 25 trades · May 13, 2026 – October 2, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 19 trades on this page.

Tax or exercise withholding

Mark Kaye

EVP & CFO

Common Stock

Value context
$1.61M
Reported price
$386.43 / share
Traded October 2, 2026Filed October 6, 2026SEC filing
Award disclosed

Mark Kaye

EVP & CFO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded October 2, 2026Filed October 6, 2026SEC filing
Tax or exercise withholding

Erin M. Wessling

EVP & Chief Legal Officer

Common Stock

Value context
$38.15K
Reported price
$405.84 / share
Traded September 2, 2026Filed September 4, 2026SEC filing
Tax or exercise withholding

Erin M. Wessling

EVP & Chief Legal Officer

Common Stock

Value context
$105.77K
Reported price
$414.78 / share
Traded September 3, 2026Filed September 4, 2026SEC filing
Tax or exercise withholding

Ryan R. Craig

EVP & Chief HR Officer

Common Stock

Value context
$58.44K
Reported price
$405.84 / share
Traded September 2, 2026Filed September 4, 2026SEC filing
Exercise or conversion

Ronald W. Penczek

CAO & Controller

Common Stock

Value context
$177.41K
Reported price
$271.27 / share
Traded May 19, 2026Filed May 20, 2026SEC filing
Exercise or conversion

Ronald W. Penczek

CAO & Controller

Common Stock

Value context
$273.17K
Reported price
$311.48 / share
Traded May 19, 2026Filed May 20, 2026SEC filing
Exercise or conversion

Ronald W. Penczek

CAO & Controller

Employee Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$271.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 19, 2026Filed May 20, 2026SEC filing
Exercise or conversion

Ronald W. Penczek

CAO & Controller

Employee Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$311.48 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 19, 2026Filed May 20, 2026SEC filing
Award disclosed

Deanna D. Strable-Soethout

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Amy W. Schulman

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Ryan M. Schneider

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Ramiro G. Peru

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Antonio F. Neri

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Bahija Jallal

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Lewis Hay III

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Robert L. Dixon JR

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Susan D. DeVore

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Steven H. Collis

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 13, 2026Filed May 15, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
EVP & CFOCommon StockExercise-price or tax withholding4,161$386.43 / share$1.61MOct 2Filed Oct 6 · 4d laterSEC filing
EVP & CFOCommon StockGrant or award2,627Award · no purchase priceNon-cash awardOct 2Filed Oct 6 · 4d laterSEC filing
EVP & Chief Legal OfficerCommon StockExercise-price or tax withholding94$405.84 / share$38.15KSep 2Filed Sep 4 · 2d laterSEC filing
EVP & Chief Legal OfficerCommon StockExercise-price or tax withholding255$414.78 / share$105.77KSep 3Filed Sep 4 · 1d laterSEC filing
EVP & Chief HR OfficerCommon StockExercise-price or tax withholding144$405.84 / share$58.44KSep 2Filed Sep 4 · 2d laterSEC filing
CAO & ControllerCommon StockOption exercise or conversion654$271.27 / share$177.41KMay 19Filed May 20 · 1d laterSEC filing
CAO & ControllerCommon StockOption exercise or conversion877$311.48 / share$273.17KMay 19Filed May 20 · 1d laterSEC filing
CAO & ControllerEmployee Stock Option (Right to Buy)Option exercise or conversionDerivative units654$271.27 exercise / conversion priceNot a separate purchaseMay 19Filed May 20 · 1d laterSEC filing
CAO & ControllerEmployee Stock Option (Right to Buy)Option exercise or conversionDerivative units877$311.48 exercise / conversion priceNot a separate purchaseMay 19Filed May 20 · 1d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award563Award · no purchase priceNon-cash awardMay 13Filed May 15 · 2d laterSEC filing

Congress transactions 2

All Congress filings
Purchase disclosed

Elevance Health, Inc. Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Purchase disclosed

Elevance Health, Inc. Common Stock · Stock

The filing reports a purchase for a joint account.

Markwayne Mullin official portraitMarkwayne MullinReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
December 29, 2025
Filed January 16, 2026 · 18d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$752,554 of common-equity purchase value after transaction-age decay across 180 days.

+20 pts

Distinct buying groups

2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+8 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+8 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+6 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001156039
Latest public acceptance
Oct 6, 2026, 08:02 PM UTC
Score calculated
Oct 8, 2026, 12:05 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.